The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $8.16 in the prior trading day, Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $440.18K, up 662926%. In other words, the price has increased by $662926 from its previous closing price. On the day, 0.66 million shares were traded. CGEM stock price reached its highest trading level at $8.18 during the session, while it also had its lowest trading level at $7.58.
Ratios:
Our goal is to gain a better understanding of CGEM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.62 and its Current Ratio is at 11.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $30.
On May 01, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $40.Stifel initiated its Buy rating on May 01, 2024, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 25 ’25 when Jones Jeffrey Alan sold 4,895 shares for $8.53 per share. The transaction valued at 41,754 led to the insider holds 174,164 shares of the business.
AHMED NADIM sold 12,529 shares of CGEM for $106,872 on Feb 25 ’25. The President and CEO now owns 430,621 shares after completing the transaction at $8.53 per share. On Feb 25 ’25, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 3,756 shares for $8.53 each. As a result, the insider received 32,039 and left with 142,004 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 452642752 and an Enterprise Value of 150655488.
Stock Price History:
The Beta on a monthly basis for CGEM is -0.04, which has changed by -0.55843407 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, CGEM has reached a high of $21.01, while it has fallen to a 52-week low of $6.85. The 50-Day Moving Average of the stock is -5.78%, while the 200-Day Moving Average is calculated to be -33.29%.
Shares Statistics:
The stock has traded on average 440.18K shares per day over the past 3-months and 328030 shares per day over the last 10 days, according to various share statistics. A total of 58.70M shares are outstanding, with a floating share count of 35.92M. Insiders hold about 39.13% of the company’s shares, while institutions hold 74.01% stake in the company. Shares short for CGEM as of 1748563200 were 6181783 with a Short Ratio of 14.04, compared to 1745971200 on 7479137. Therefore, it implies a Short% of Shares Outstanding of 6181783 and a Short% of Float of 12.1199995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
